NewGen Reports Nine-Month 2025 Results with Balance Sheet Strengthened to $66.75 Net Asset Value Per Share

About this update from Newgenivf Group Limited

[{"type":"text","content":"BANGKOK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or “the Company”), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today reported its unaudited financial results for the nine months ended September 30, 2025.","length":338,"tagName":"p"},{"type":"text","content":"Financial Highlights for the Nine Months Ended September 30, 2025","length":65,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to the shareholders of the Company was $17.5 million, a significant improvement from a net loss of $416,400 in the same period of 2024. This was primarily due to a non-cash, bargain purchase gain recognized on the acquisition of Nodexus and Microsort businesses.","length":286,"tagName":"p"}]},{"val":[{"type":"text","content":"Basic earnings per share was $96.76 for the nine months ended September 30, 2025 while losses per share for the nine months ended September 30, 2024 was $205.97.","length":161,"tagName":"p"}]},{"val":[{"type":"text","content":"Net book value per share improved to $66.75 from negative net book value as of December 31, 2024, representing a significant balance sheet transformation driven by strategic acquisitions of high-value intellectual property assets.","length":230,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":677,"olType":false},{"type":"text","content":"Business Highlights for the Nine Months Ended September 30, 2025","length":64,"tagName":"p"},{"type":"text","content":"The Company has made significant progress in executing its strategic pivot and diversification strategy throughout 2025. Key initiatives and achievements demonstrating this progress include:","length":190,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Transformative Acquisitions: The Company completed two key acquisitions.","length":72,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"On February 28, 2025, the Company acquired the MicroSort® sperm-sorting technology, enhancing its capabilities in the fertility services market. The acquisition also resulted in a prior bargain purchase gain of $4.28 million based on an independent valuation report.","length":266,"tagName":"p"}]},{"val":[{"type":"text","content":"On J...

More updates from Newgenivf Group Limited